AUM $3.1MER —NAV —Holdings 24Inception Dec 2021
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
81Dividend Yield
—Expense Ratio
—AUM
$3.1MShares Outstanding
—ETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Country Allocation
| Country | Weight % |
|---|---|
| United States | 89.32% |
| Germany | 9.15% |
| Netherlands | 1.54% |
Fund Information
- Issuer
- Direxion
- Types
- EuropeTechnology
- Inception Date
- Dec 9, 2021
- Description
- The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA (“mRNA”) technology. The fund is non-diversified.
The Direxion mRNA ETF (MSGR) is an exchange-traded fund issued by Direxion that launched on Dec 9, 2021. It currently manages $3.1M in assets under management. The fund holds 24 securities in its portfolio.
Top 10 holdings represent 64.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals | 8.09% | 769 | $253K |
| 2 | BGNE | BeiGene Ltd | 7.51% | 910 | $235K |
| 3 | ARCT | Arcturus Therapeutics Holdings Inc | 7.45% | 8,672 | $233K |
| 4 | SCLX | SCLX | 6.82% | 17,433 | $213K |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | 6.45% | 994 | $202K |
| 6 | PTCT | PTC THERAPEUTICS INC USD 0.001 | 6.31% | 3,669 | $197K |
| 7 | BNTX | BIONTECH SE | 5.76% | 1,490 | $180K |
| 8 | MRNA | Moderna Inc | 5.60% | 1,240 | $175K |
| 9 | SRPT | SAREPTA THERAPEUTICS INC | 5.30% | 1,313 | $166K |
| 10 | MRVI | Maravai LifeSciences Holdings Inc | 4.93% | 10,940 | $154K |
| 11 | NTLA | Intellia Therapeutics Inc | 4.33% | 3,787 | $135K |
| 12 | IONS | IONIS PHARMACEUTICALS INC | 4.10% | 3,548 | $128K |
| 13 | ARWR | ARROWHEAD PHARMACEUTICALS IN | 3.68% | 3,846 | $115K |
| 14 | RNA | AVIDITY BIOSCIENCES INC | 3.67% | 7,285 | $115K |
| 15 | CVAC | CureVac NV | 3.38% | 13,325 | $106K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | — | |
| 5Y | -42.81% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$13.91
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with MSGR:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.